AURORA, Colo. & BOULDER, Colo.--(BUSINESS WIRE)--Children’s Hospital Colorado and SomaLogic, Inc., announced today that they have entered into a collaborative agreement to discover protein biomarkers and use those biomarkers to develop laboratory tests to improve the diagnosis and management of childhood diseases. The discovery and development work will be done using SomaLogic’s novel proteomics SOMAscan™ assay, which can measure more than a thousand proteins in a small amount of blood or other biological samples. This innovative collaboration is being entered into as a result of successful initial exploratory research done by the two organizations.
Help employers find you! Check out all the jobs and post your resume.
